A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants ...

Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.

More Alberta seniors are now eligible for a provincially funded RSV vaccine. The provincial government announced in October ...

The state Department of Health reported “very high” levels of flu statewide between Feb. 23 and March 1. DOH also reported ...

Feb. 19, 2025 – A vaccine for pregnant women that protects babies from respiratory syncytial virus (RSV) appears safe, according to two new studies that give researchers hope for widespread ...

More Alberta seniors are now eligible for a provincially funded RSV vaccine. The provincial government announced in October it would provide the RSV shot, Abrysvo, for free to seniors 60 and up ...

GSK's vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also one with considerable competition, so needs strong data to support the programme.

Uruguay's Public Health Ministry (MSP) launched its 2025 vaccination campaign, focusing on influenza, measles, and ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

The incident occurred months after health authorities discovered the GP’s clinic had incorrectly stored vaccines, potentially ...